Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantifying lateral tissue heterogeneities in hadron therapy.

D Pflugfelder1, J J Wilkens, H Szymanowski

  • 1Department of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. d.pflugfelder@dkfz.de

Medical Physics
|May 16, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is rectal preparation necessary in contemporary image-guided prostate radiotherapy?

Clinical and translational radiation oncology·2026
Same author

Ultrahypofractionated radiotherapy for localised prostate cancer: The impact of daily MRI-guided adaptive radiotherapy on delivered dose.

Clinical and translational radiation oncology·2025
Same author

Patient experience preparing for prostate cancer radiotherapy.

Technical innovations & patient support in radiation oncology·2025
Same author

A Four-dimensional Computed Tomography Generated Internal Target Volume Approach to Paediatric High Risk Neuroblastoma to Reduce Organ at Risk and Normal Tissue Irradiation.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Prostate cancer image guided radiotherapy: Why the commotion over rectal volume and motion?

Clinical and translational radiation oncology·2023
Same author

GI factors, potential to predict prostate motion during radiotherapy; a scoping review.

Clinical and translational radiation oncology·2023
Same journal

Correction to "On the shape of the radiation survival curve in tumor spheroids: The role of oxygen heterogeneity".

Medical physics·2026
Same journal

Multi-view constrained semi-supervised vertebra detection for 3D ultrasound spine volume.

Medical physics·2026
Same journal

Accuracy of quantitative <sup>177</sup>Lu SPECT/CT imaging: A systematic review.

Medical physics·2026
Same journal

Physics-constrained dual-domain network for CBCT reconstruction from orthogonal X-rays in gynecologic radiotherapy.

Medical physics·2026
Same journal

Decomposition-based harmonization for quantitative PET imaging across scanners and radiotracers.

Medical physics·2026
Same journal

Development and evaluation of an in vivo dose-based monitoring system for electron FLASH radiation therapy.

Medical physics·2026
See all related articles

A new heterogeneity number quantifies lateral tissue variations in scanned particle beam radiotherapy. This metric helps assess risks from dose calculation and setup errors, improving treatment plan robustness.

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Radiotherapy Physics

Background:

  • Tissue heterogeneities lateral to the beam path complicate radiotherapy dose calculations.
  • These heterogeneities increase sensitivity to patient setup errors in scanned particle beam treatments.

Purpose of the Study:

  • Introduce a heterogeneity number H(i) to quantify lateral tissue heterogeneities for individual beam spots.
  • Evaluate H(i)'s correlation with dose calculation and setup errors in scanned proton therapy.

Main Methods:

  • Developed a heterogeneity number H(i) for single beam spots.
  • Compared pencil beam algorithm dose calculations with Monte Carlo simulations to assess dose calculation errors.
  • Analyzed the sensitivity of single beam spots to setup errors.

Related Experiment Videos

Main Results:

  • Dose calculation errors showed a clear correlation with the heterogeneity number H(i).
  • Sensitivity to setup errors also demonstrated a dependence on H(i).
  • H(i) effectively quantifies risks associated with lateral tissue heterogeneities.

Conclusions:

  • H(i) serves as a criterion to assess risks from lateral tissue heterogeneities in radiotherapy.
  • Incorporating H(i) into inverse planning for intensity-modulated proton therapy can create more robust treatment plans.
  • Suppressing high H(i) beam spots reduces the impact of heterogeneities and improves plan reliability.